{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T17:32:35Z","timestamp":1785346355756,"version":"3.55.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.jiac.2021.06.021","type":"journal-article","created":{"date-parts":[[2021,7,4]],"date-time":"2021-07-04T21:28:26Z","timestamp":1625434106000},"page":"1482-1488","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["The estimated burden of 15 vaccine-preventable diseases from 2008 to 2020 in Japan: A transition by the COVID-19 pandemic"],"prefix":"10.1016","volume":"27","author":[{"given":"Taito","family":"Kitano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.jiac.2021.06.021_bib1","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1093\/cid\/ciy779","article-title":"Characteristics of large mumps outbreaks in the United States, july 2010-December 2015","volume":"68","author":"Clemmons","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.jiac.2021.06.021_bib2","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2019-0414","article-title":"Spread of measles in europe and implications for US travelers","volume":"144","author":"Angelo","year":"2019","journal-title":"Pediatrics"},{"key":"10.1016\/j.jiac.2021.06.021_bib3","author":"National Institute of Infectious Diseases"},{"issue":"4","key":"10.1016\/j.jiac.2021.06.021_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0231966","article-title":"Conjunctivitis, the key clinical characteristic of adult rubella in Japan during two large outbreaks, 2012-2013 and 2018-2019","volume":"15","author":"Nomoto","year":"2020","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.jiac.2021.06.021_bib5","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/21645515.2020.1765619","article-title":"Close the gap for routine mumps vaccination in Japan","volume":"17","author":"Kitano","year":"2021","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.jiac.2021.06.021_bib6","doi-asserted-by":"crossref","DOI":"10.33321\/cdi.2021.45.11","article-title":"Notifiable diseases after implementation of COVID-19 public health prevention measures in Central Queensland, Australia","volume":"45","author":"Adegbija","year":"2021","journal-title":"Comm Dis Intell"},{"key":"10.1016\/j.jiac.2021.06.021_bib7","first-page":"ciaa1682","article-title":"Impact of non-pharmaceutical interventions on the incidence of respiratory infections during the COVID-19 outbreak in Korea: a nationwide surveillance study","author":"Huh","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.jiac.2021.06.021_bib8","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.vaccine.2020.12.080","article-title":"Short term impact of the COVID-19 pandemic on incidence of vaccine preventable diseases and participation in routine infant vaccinations in The Netherlands in the period March-September 2020","volume":"39","author":"Middeldorp","year":"2021","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.jiac.2021.06.021_bib9","doi-asserted-by":"crossref","first-page":"2001718","DOI":"10.1183\/13993003.01718-2020","article-title":"The potential impact of COVID-19-related disruption on tuberculosis burden","volume":"56","author":"McQuaid","year":"2020","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.jiac.2021.06.021_bib10","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.vaccine.2020.11.053","article-title":"A model for the incremental burden of invasive Haemophilus influenzae type b due to a decline of childhood vaccination during the COVID-19 outbreak: a dynamic transmission model in Japan","volume":"39","author":"Kitano","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.jiac.2021.06.021_bib11","first-page":"1","article-title":"The estimated impact of decreased childhood vaccination due to COVID-19 using a dynamic transmission model of mumps in Japan","author":"Kitano","year":"2020","journal-title":"Hum Vaccines Immunother"},{"issue":"10258","key":"10.1016\/j.jiac.2021.06.021_bib12","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"Gbd 2019 Diseases","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jiac.2021.06.021_bib13","author":"National Institute of Infectious Diseases"},{"key":"10.1016\/j.jiac.2021.06.021_bib14","author":"Japan Pediatric Society"},{"key":"10.1016\/j.jiac.2021.06.021_bib15","author":"Know"},{"key":"10.1016\/j.jiac.2021.06.021_bib18","series-title":"Pertussis vaccine factsheet","year":"2017"},{"key":"10.1016\/j.jiac.2021.06.021_bib20","series-title":"Life table in","year":"2019"},{"issue":"18","key":"10.1016\/j.jiac.2021.06.021_bib22","doi-asserted-by":"crossref","first-page":"1800363","DOI":"10.2807\/1560-7917.ES.2019.24.18.1800363","article-title":"Disease burden of varicella versus other vaccine-preventable diseases before introduction of vaccination into the national immunisation programme in The Netherlands","volume":"24","author":"van Lier","year":"2019","journal-title":"Euro Surveill"},{"issue":"7","key":"10.1016\/j.jiac.2021.06.021_bib23","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.vaccine.2015.12.052","article-title":"Burden of four vaccine preventable diseases in older adults","volume":"34","author":"Kristensen","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.jiac.2021.06.021_bib24","first-page":"1","article-title":"Department of data and analytics Division of data, analytics and Delivery for impact WHO, geneva","volume":"3","author":"World Health Organization","year":"2020","journal-title":"WHO methods and data sources for global burden of disease estimates 2000-2019"},{"issue":"9859","key":"10.1016\/j.jiac.2021.06.021_bib25","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0140-6736(12)61689-4","article-title":"Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Murray","year":"2012","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.jiac.2021.06.021_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079740","article-title":"The pathogen- and incidence-based DALY approach: an appropriate [corrected] methodology for estimating the burden of infectious diseases","volume":"8","author":"Mangen","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.jiac.2021.06.021_bib28","author":"Kawado"},{"issue":"1","key":"10.1016\/j.jiac.2021.06.021_bib29","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12879-020-4801-x","article-title":"Estimating nationwide cases of sexually transmitted diseases in 2015 from sentinel surveillance data in Japan","volume":"20","author":"Kawado","year":"2020","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jiac.2021.06.021_bib30","author":"Cancer Registry and Statistics"},{"issue":"6","key":"10.1016\/j.jiac.2021.06.021_bib31","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1442-200X.1989.tb01379.x","article-title":"National project on the prevention of mother-to-infant infection by hepatitis B virus in Japan","volume":"31","author":"Eto","year":"1989","journal-title":"Acta Paediatr Jpn"},{"issue":"8","key":"10.1016\/j.jiac.2021.06.021_bib32","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jiac.2019.03.014","article-title":"Hepatitis B virus infection: prevention of mother-to-child transmission and exacerbation during pregnancy","volume":"25","author":"Sasagawa","year":"2019","journal-title":"J Infect Chemother"},{"issue":"6","key":"10.1016\/j.jiac.2021.06.021_bib33","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/hepr.12897","article-title":"Current activities and future directions of comprehensive hepatitis control measures in Japan: the supportive role of the Hepatitis Information Center in building a solid foundation","volume":"47","author":"Oza","year":"2017","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jiac.2021.06.021_bib34","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.3201\/eid2411.180326","article-title":"Effects of pneumococcal conjugate vaccine on genotypic penicillin resistance and serotype changes, Japan, 2010-2017","volume":"24","author":"Ubukata","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jiac.2021.06.021_bib35","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/j.vaccine.2019.12.022","article-title":"Nationwide surveillance of paediatric invasive and non-invasive pneumococcal disease in Japan after the introduction of the 13-valent conjugated vaccine, 2015-2017","volume":"38","author":"Nakano","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.jiac.2021.06.021_bib36","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/irv.12486","article-title":"Annual estimates of the burden of seasonal influenza in the United States: a tool for strengthening influenza surveillance and preparedness","volume":"12","author":"Rolfes","year":"2018","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.jiac.2021.06.021_bib37","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ijid.2019.08.003","article-title":"Investigating the impact of influenza on excess mortality in all ages in Italy during recent seasons (2013\/14-2016\/17 seasons)","volume":"88","author":"Rosano","year":"2019","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jiac.2021.06.021_bib40","doi-asserted-by":"crossref","first-page":"104429","DOI":"10.1016\/j.compbiomed.2021.104429","article-title":"The incremental burden of invasive pneumococcal disease associated with a decline in childhood vaccination using a dynamic transmission model in Japan: a secondary impact of COVID-19","volume":"133","author":"Kitano","year":"2021","journal-title":"Comput Biol Med"},{"key":"10.1016\/j.jiac.2021.06.021_bib41","series-title":"Active tuberculosis","author":"Jilani","year":"2020"},{"key":"10.1016\/j.jiac.2021.06.021_bib42","doi-asserted-by":"crossref","first-page":"m1447","DOI":"10.1136\/bmj.m1447","article-title":"Covid-19: Japan declares state of emergency as Tokyo cases soar","volume":"369","author":"Looi","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.jiac.2021.06.021_bib43","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1016\/j.vaccine.2021.05.050","article-title":"Changes in childhood vaccination during the coronavirus disease 2019 pandemic in Japan","volume":"39","author":"Aizawa","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.jiac.2021.06.021_bib44","doi-asserted-by":"crossref","first-page":"110465","DOI":"10.1016\/j.mehy.2020.110465","article-title":"Reduction in the incidence of infectious diseases during the COVID-19 pandemic: a hypothesis","volume":"146","author":"MohammadSadeghi","year":"2021","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.jiac.2021.06.021_bib45","series-title":"Practice guidance of suspected patients with novel coronavirus infection","first-page":"1202","volume":"vol. 461","author":"Japan Medical Association","year":"2020"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X21001835?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X21001835?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:03:06Z","timestamp":1761159786000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X21001835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S1341321X21001835"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2021.06.021","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The estimated burden of 15 vaccine-preventable diseases from 2008 to 2020 in Japan: A transition by the COVID-19 pandemic","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2021.06.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}